Related Experiment Video

Updated: May 29, 2026

Left Lung Orthotopic Transplantation in a Juvenile Porcine Model for ESLP
06:55

Left Lung Orthotopic Transplantation in a Juvenile Porcine Model for ESLP

Published on: February 14, 2022

Challenges during repeat extracorporeal life support in a patient with pulmonary alveolar proteinosis

Hemanth Lingadevaru1, Matthew A Romano, Karen Fauman

  • 1Pediatric Critical Care Medicine, University of Michigan, Ann Arbor, Michigan 48109, USA.

ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|August 30, 2011
PubMed

Insights

Extracorporeal life support (ECLS) can aid pulmonary alveolar proteinosis (PAP) patients. Alternative cannulation strategies are vital for pediatric patients needing repeat ECLS due to PAP, as standard methods may fail.

Area of Science:

  • Pediatric critical care medicine
  • Cardiopulmonary support technologies

Background:

  • Pulmonary alveolar proteinosis (PAP) is a rare lung disease requiring respiratory support.
  • Extracorporeal life support (ECLS) is a life-saving measure for severe respiratory failure in PAP.
  • Pediatric patients may require multiple ECLS courses for recurrent PAP episodes.

Observation:

  • A 12-year-old girl with PAP experienced respiratory failure and required ECLS for the second time.
  • Initial venovenous-arterial (VVA) ECLS was transitioned to venovenous (VV) ECLS.
  • Unique cannulation involving right femoral vein drainage and right atrial reinfusion was necessary due to prior ECLS.

Findings:

  • Standard ECLS cannulation techniques may be infeasible in pediatric patients undergoing a second ECLS course for PAP.
  • Alternative cannulation strategies and ECLS configurations are crucial for successful support in complex cases.
  • Successful management required adapting ECLS to the patient's unique anatomical and clinical circumstances.

Implications:

  • This case highlights the need for flexible and individualized ECLS approaches in pediatric respiratory failure.
  • Clinicians should anticipate challenges with standard cannulation in children with prior ECLS.
  • Further research into novel ECLS cannulation techniques for pediatric patients with chronic respiratory conditions is warranted.

More Related Videos

Exploring Alternative Perfusion Solutions Using Next-Generation Polymerized Hemoglobin-Based Oxygen Carriers in a Model of Rat Ex Vivo Lung Perfusion09:47

Exploring Alternative Perfusion Solutions Using Next-Generation Polymerized Hemoglobin-Based Oxygen Carriers in a Model of Rat Ex Vivo Lung Perfusion

Published on: June 14, 2024

Method of Isolated Ex Vivo Lung Perfusion in a Rat Model: Lessons Learned from Developing a Rat EVLP Program08:59

Method of Isolated Ex Vivo Lung Perfusion in a Rat Model: Lessons Learned from Developing a Rat EVLP Program

Published on: February 25, 2015

Related Concept Videos

Pulmonary Edema II: Pathophysiology01:18

Pulmonary Edema II: Pathophysiology

Pulmonary edema is the accumulation of fluid in the interstitial and alveolar spaces of the lungs, impairing gas exchange and oxygen delivery. It may be cardiogenic or noncardiogenic, but both reduce oxygenation and lung compliance.Cardiogenic Pulmonary EdemaCardiogenic edema results from increased hydrostatic pressure in pulmonary capillaries, usually due to left ventricular dysfunction from myocardial infarction, heart failure, or valvular disease. Ineffective cardiac pumping causes blood to...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...